POTENTIAL FUTURE DEVELOPMENTS

Our researchers are focused on taking rigorous yet innovative approaches to develop a robust pipeline covering disease areas with the highest unmet medical needs. Our currently commercialised tests on the abioSCOPE® platform include the pancreatic stone protein (PSP) sepsis diagnosis test, the cSOFA severity score test for COVID-19, the allergy panel test and the iron deficiency ferritin blood test. Additional point-of-care tests are under development and will be launched soon.

We are committed to providing healthcare professionals with fast and reliable results at the point of care, with the highest test efficiency and medical value.

We can develop an extensively wide range of clinical diagnostic applications in healthcare in specific disease areas thanks to our cutting-edge nanofluidic technology. Discover an overview of the potential development opportunities offered by our solutions by clicking on the images below:

 

 

Interested in partnership opportunities? Contact us for a partnership on a specific development

*Test available on the abioSCOPE® platform

Contact us

Cardiovascular diseases
Sepsis & infectious diseases
Critical care
IMMUNOLOGY & ENDOCRINOLOGY
Metabolism
Therapeutic drug monitoring
HAEMATOLOGY
Traumatic brain injuries
Cardiovascular diseases
Markers Indications Technology Assay time
fec159
  1. D-Dimer*

  2. Cardiac troponin I (cTnI)
  3. Pro B-type natriuretic peptide (ProBNP)
  4. Creatinine kinase - muscle/brain (CK-MB)
  5. High sensitive C-reactive protein (hsCRP)
  1. Venous thromboembolic diseases
  2. Myocardial infarction
  3. Heart failure (prognosis)

  4. Acute myocardial infarction

  5. Risk of cardiovascular disease
Immunoassay
5 minutes
Sepsis & infectious diseases
Markers Indications Technology Assay time
fa4615
  1. Pancreatic stone protein (PSP)*
  2. C-reactive protein (CRP)
  3. Procalcitonin (PCT)
  4. C. difficile ToxA/B
  5. Dengue virus NS1 and IgM
  6. HIV
  7. SARS-Cov-2*
  1. Sepsis
  2. Inflammation
  3. Bacteremia
  4. C. difficile infection
  5. Dengue fever
  6. AIDS
  7. COVID-19
Immunoassay
5-8 minutes
fa4615
  1. Emerging virus panel

  2. Influenza panel
  3. Respiratory panel




  4. Gastrointestinal (GI) panel




  5. Sexually transmitted infection (STI) panel



  6. Antimicrobial resistance panel
  1. Viral infection: Dengue, Zika, Ebola, SARS ...
  2. Viral infection: Influenza A, B
  3. Respiratory tract infection: Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Pseudomonas aeruginosa...
  4. Gastrointestinal infection: Escherichia coli, Campylobacter (jejuni, coli, and upsaliensis), Clostridium difficile (toxin A/B), Salmonella...
  5. Sexually transmitted infection: Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG), Group B Streptococcus (GBS), Trichomonas vaginalis (TV)...
  6. Antimicrobial resistance gene : ESBL (CTX-M), Carbapenemase (KPC), Methicillin Resistance (mecA/mecC) ...
Molecular diagnosis
30 minutes
Critical care
Markers Indications Technology Assay time
acc1e0
  1. Undisclosed biomarker
  2. Alkaline phosphatase (ALP), aspartate aminotransferase (AST), alanine aminotransferase (ALT)
  3. Albumin
  1. Acute kidney injury
  2. Liver function / liver injury



  3. Hypoalbuminemia
Immunoassay
5-8 minutes
acc1e0
  1. pH
  2. pCO2, pO2, sO2
  3. K+, Na+, Ca2+, Cl-
  4. Lactate
  1. Acid-base imbalance
  2. Electrolyte imbalance
  3. Electrolyte imbalance
  4. Hypoxia
Electrochemistry
1 minute
acc1e0
  1. Urea
  2. Creatinine
  1. Kidney function
  2. Kidney function
Enzymatic reaction
5 minutes
IMMUNOLOGY & ENDOCRINOLOGY
Markers Indications Technology Assay time
d5b1d3
  1. Tryptase
  2. Thyroid panel (thyroid stimulating hormone (TSH), free/total T3/T4)
  3. Neonatal thyroid panel (TSH, Thyroxin)
  4. Human chorionic gonadotropin (hCG)
  5. Placental growth factor
  1. Anaphylactic shock
  2. Thyroid storm, hyperthyroidism


  3. Thyroid storm, hyperthyroidism

  4. Pregnancy

  5. Pre-eclampsia
Immunoassay
5-10 minutes
d5b1d3
  1. Total IgE*
  2. sIgE Derp 1 + Der p 2 *
  3. sIgE Phl p 1 + Phl p 5*
  4. sIgE Alt a 1*
  5. sIgE Fel d 1*
  6. sIgE Can f 1*
  1. Allergy
  2. Allergy to House Dust Mite
  3. Allergy to Timothy Grass
  4. Allergy to Alternaria Alternata
  5. Allergy to Cat
  6. Allergy to Dog
Immunoassay
5-8 minutes
Metabolism
Markers Indications Technology Assay time
2b4cef
  1. Glucose
  1. Hypo and hyperglycemia
Electrochemistry
1 minute
2b4cef
  1. Glycated hemoglobin (HbA1c)
  1. Diabetes (diagnosis and monitoring)
Boronate chromatography
3 minutes
Therapeutic drug monitoring
Markers Indications Technology Assay time
adadab
  1. Anti-TNFα
  2. Antiepileptics (carbamazepine, phenobarbital, valproic acid)

  3. Antiarrhythmics (digitoxin, digoxin, lidocaine)

  4. Antibiotics (vancomycin)

  5. Bronchodilators (theophylline)
  6. Immunosuppressants (cyclosporine, tacrolimus)
  1. Inflammatory bowel disease
  2. Correction of abnormal neuronal discharge in the central nervous system
  3. Correction of cardiac abnormalities (tachycardia, bradycardia)
  4. Vancomycin-sensitive bacterial infection
  5. Chronic asthma
  6. Organ transplant, cancers
Immunoassay
5 minutes
HAEMATOLOGY
Markers Indications Technology Assay time
d03331
  1. Ferritin*
  1. Anemia (iron-deficiency anemia)
Immunoassay
5 minutes
d03331
  1. Hemoglobin
  1. Anemia
Photometry
1 minute
d03331
  1. Erythrocyte
  2. White blood cells



  3. Neutrophils
  4. Basophils
  5. Eosinophils
  6. Lymphocytes

  7. Thrombocytes
  1. Anemia
  2. Leukopenia (immunosuppression, immunocompromised), anemia, infection, leukemia
  3. Neutropenia
  4. Basophilia, basopenia
  5. Eosinophilia
  6. Lymphocytopenia, lymphocytosis
  7. Thrombocytopenia, thrombocytosis and thrombocythemia
Flow cytometry
1 minute
Traumatic brain injuries
Markers Indications Technology Assay time
000000
  1. Undisclosed marker
  1. Traumatic brain injury
Immunoassay
5–8 minutes